Schering-Plough
SGP
#544
Rank
A$65.62 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Cash on Hand

Cash on Hand as of December 2008 : A$4.79 Billion

According to Schering-Plough's latest financial reports the company has A$4.79 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Schering-Plough - Cash on Hand chart (from 1996 to 2008)

Cash on Hand by year

Year Cash on Hand Change
2008-12-31A$4.78 B
2006-12-31A$3.38 B-48.09%
2005-12-31A$6.51 B1.16%
2004-12-31A$6.44 B13.5%
2003-12-31A$5.67 B260.04%
2002-12-31A$1.57 B-32.23%
2001-12-31A$2.32 B82.64%
2000-12-31A$1.27 B
1998-12-31A$1.31 B25.38%
1997-12-31A$1.04 B114.46%
1996-12-31A$0.48 B